Dammann, K and Khare, V and Lang, M and Claudel, T and Harpain, F and Granofszky, N and Evstatiev, R and Williams, J M and Pritchard, D M and Watson, A and Gasche, C (2015) PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1853 (10A). pp. 2349-2360.
|
Text
11735.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
P21-activated kinases (PAKs) are multifunctional effectors of Rho GTPases with both kinase and scaffolding activity. Here, we investigated the effects of inflammation on PAK1 signaling and its role in colitis-driven carcinogenesis. PAK1 and p-PAK1 (Thr423) were assessed by immunohistochemistry, immunofluorescence, and Western blot. C57BL6/J wildtype mice were treated with a single intraperitoneal TNFα injection. Small intestinal organoids from these mice and from PAK1-KO mice were cultured with TNFα. NF-κB and PPARγ were analyzed upon PAK1 overexpression and silencing for transcriptional/translational regulation. PAK1 expression and activation was increased on the luminal intestinal epithelial surface in inflammatory bowel disease and colitis-associated cancer. PAK1 was phosphorylated upon treatment with IFNγ, IL-1β, and TNFα. In vivo, mice administered with TNFα showed increased p-PAK1 in intestinal villi, which was associated with nuclear p65 and NF-κB activation. p65 nuclear translocation downstream of TNFα was strongly inhibited in PAK1-KO small intestinal organoids. PAK1 overexpression induced a PAK1–p65 interaction as visualized by co-immunoprecipitation, nuclear translocation, and increased NF-κB transactivation, all of which were impeded by kinase-dead PAK1. Moreover, PAK1 overexpression downregulated PPARγ and mesalamine recovered PPARγ through PAK1 inhibition. On the other hand PAK1 silencing inhibited NF-κB, which was recovered using BADGE, a PPARγ antagonist. Altogether these data demonstrate that PAK1 overexpression and activation in inflammation and colitis-associated cancer promote NF-κB activity via suppression of PPARγ in intestinal epithelial cells.
| Item Type: | Article |
|---|---|
| DOI: | https://doi.org/10.1016/j.bbamcr.2015.05.031 |
| Departments: | Pathobiology and Population Sciences |
| Depositing User: | Michael Murphy |
| Last Modified: | 21 Feb 2020 01:53 |
| URI: | http://researchonline.rvc.ac.uk/id/eprint/11735 |
| Date Deposited: | 6 September 2018 |